US Patent 11840553 Anti-CD47 antibodies and methods of use thereof
Patent 11840553 was granted and assigned to NovImmune SA on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+33 properties)
Article (+594 characters)
US Patent 11840553 Anti-CD47 antibodies and methods of use thereof
Article
Patent abstract
The invention relates to monoclonal and/or monovalent antibodies that bind CD47. The invention relates to monoclonal and/or monovalent antibodies that bind CD19. The invention also relates to novel bispecific monoclonal antibodies carrying a different specificity for each binding site of the immunoglobulin molecule, where one of the binding sites is specific for CD47. The invention also relates to novel bispecific monoclonal antibodies carrying a different specificity for each binding site of the immunoglobulin molecule, where one of the binding sites is specific for CD19.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Elie Dheilly0
Francois Rousseau0
Krzysztof Masternak0
Marie Kosco-Vilbois0
Nicolas Fischer0
Date of Patent
December 12, 2023
0Patent Application Number
160156010
Date Filed
June 22, 2018
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11840553 Anti-CD47 antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
